baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Morgan Stanley Knock-Out BMY/ DE000MG3C4V9 /

11/09/2024 19:54:52	Chg.-0.04	Bid20:25:55	Ask20:25:55	Underlying	Strike price	Expiration date	Option type
1.64EUR	-2.38%	1.62 Bid Size: 50,000	1.63 Ask Size: 50,000	Bristol Myers Squibb...	30.6898 USD	31/12/2078	Call

GlobeNewswire 03/09 Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer

GlobeNewswire 02/09 CSE Announces its 2024 Sustainability & ESG Leadership Summit at NYC's One World Trade Center

GlobeNewswire 30/08 Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire 29/08 Immunocore announces transition of Chief Financial Officer

GlobeNewswire 28/08 Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising A...

GlobeNewswire 22/08 Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive ...

GlobeNewswire 15/08 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...

GlobeNewswire 12/08 Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...

Newsfile Corp 12/08 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

GlobeNewswire 12/08 Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer

GlobeNewswire 08/08 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 07/08 Efficacy and Safety Data of Sotagliflozin in Patients with Type 1 Diabetes and Chronic Kidney Diseas...

GlobeNewswire 06/08 ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors

GlobeNewswire 05/08 iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer

GlobeNewswire 01/08 Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...

GlobeNewswire 01/08 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024

GlobeNewswire 31/07 Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Boar...

GlobeNewswire 30/07 Anaveon appoints Dieter Weinand as Chair of its Board of Directors

GlobeNewswire 25/07 Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule

GlobeNewswire 24/07 Prota Therapeutics Strengthens Board with Appointment of Global Biotech Expert Patrick Machado

GlobeNewswire 20/07 NCLA Asks Third Circuit to Rule Against HHS’s Coercive Medicare Drug Price ‘Negotiation’ Program

GlobeNewswire 17/07 Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice Preside...

GlobeNewswire 09/07 VYNE Therapeutics Announces Appointment of Subhashis Banerjee, M.D. as Senior Vice President of Clin...

GlobeNewswire 09/07 Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors

GlobeNewswire 08/07 Lexeo Therapeutics Appoints Tim Van Hauwermeiren to its Board of Directors

Morgan Stanley Knock-Out BMY/ DE000MG3C4V9 /

If you wish to receive reply to your feedback, please provide your email address.